1) Matozaki T, Murata Y, Okazawa H, et al. Functions and molecular mechanisms of the CD47-SIRP alpha signaling pathway. Trends in Cell Biol. 2009; 19: 72-80
|
|
|
2) Oshima K, Ruhul Amin AR, Suzuki A, et al. SHPS-1, a multifunctional transmembrane glycoprotein. FEBS Lett. 2002; 519: 1-7
|
|
|
3) van Beek EM, Cochrane F, Barclay AN, et al. Signal regulatory proteins in the immune system. J Immunol. 2005; 175: 7781-7
|
|
|
4) Barclay AN, Brown MH. The SIRP family of receptors and immune regulation. Nat Rev Immunol. 2006; 6: 457-64
|
|
|
5) Takenaka K, Prasolava TK, Wang JC, et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol. 2007; 8: 1313-23
|
|
|
6) Jaiswal S, Jamieson CH, Pang WW, et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 2009; 138: 271-85
|
|
|
7) Majeti R, Chao MP, Alizadeh AA, et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell. 2009; 138: 286-99
|
|
|
8) Takizawa H, Manz MG. Macrophage tolerance: CD47-SIRP-alpha-mediated signals matter. Nat Immunol. 2007; 8: 1287-9
|
|
|
9) Ritchie DS, Smyth MJ. A new therapeutic target for leukemia comes to the surface. Cell. 2009; 138: 226-8
|
|
|
10) Jaiswal S, Chao MP, Majeti R, et al. Macrophages as mediators of tumor immunosurveillance. Trends Immunol. 2010; 31: 212-9
|
|
|
11) Neel BG, Gu H, Pao L. The ʻShpʼing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci. 2003; 28: 284-93
|
|
|
12) Timms JF, Swanson KD, Marie-Cardine A, et al. SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages. Curr Biol. 1999; 9: 927-30
|
|
|
13) Seiffert M, Cant C, Chen Z, et al. Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47. Blood. 1999; 94: 3633-43
|
|
|
14) Adams S, van der Laan LJ, Vernon-Wilson E, et al. Signal-regulatory protein is selectively expressed by myeloid and neuronal cells. J Immunol. 1998; 161: 1853-9
|
|
|
15) Inagaki K, Yamao T, Noguchi T, et al. SHPS-1 regulates integrin-mediated cytoskeletal reorganization and cell motility. EMBO J. 2000; 19: 6721-31
|
|
|
16) Jiang P, Lagenaur CF, Narayanan V. Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem. 1999; 274: 559-62
|
|
|
17) Brown EJ, Frazier WA. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol. 2001; 11: 130-5
|
|
|
18) Liu Y, Tong Q, Zhou Y, et al. Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47. J Mol Biol. 2007; 365: 680-93
|
|
|
19) Hatherley D, Harlos K, Dunlop DC, et al. The structure of the macrophage signal regulatory protein alpha (SIRP alpha) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors. J Biol Chem. 2007; 282: 14567-75
|
|
|
20) Nakaishi A, Hirose M, Yoshimura M, et al. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47. J Mol Biol. 2008; 375: 650-60
|
|
|
21) Hatherley D, Graham SC, Turner J, et al. Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47. Mol Cell. 2008; 31: 266-77
|
|
|
22) Oldenborg PA, Zheleznyak A, Fang YF, et al. Role of CD47 as a marker of self on red blood cells. Science. 2000; 288: 2051-4
|
|
|
23) Khandelwal S, van Rooijen N, Saxena RK. Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation. Transfusion. 2007; 47: 1725-32
|
|
|
24) Blazar BR, Lindberg FP, Ingulli E, et al. CD47(integrin-associated protein)engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells. J Exp Med. 2001; 194: 541-9
|
|
|
25) Tsai RK, Discher DE. Inhibition of“self"engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J Cell Biol. 2008; 180: 989-1003
|
|
|
26) Gardai SJ, McPhillips KA, Frasch SC, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell. 2005; 123: 321-34
|
|
|
27) Subramanian S, Parthasarathy R, Sen S, et al. Species- and cell type-specific interactions between CD47 and human SIRP alpha. Blood. 2006; 107: 2548-56
|
|
|
28) Ide K, Wang H, Tahara H, et al. Role for CD47-SIRP alpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci U S A. 2007; 104: 5062-6
|
|
|
29) Ohnishi H, Kaneko Y, Okazawa H, et al. Differential localization of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 and CD47 and its molecular mechanisms in cultured hippocampal neurons. J Neurosci. 2005; 25: 2702-11
|
|
|
30) Seiffert M, Brossart P, Cant C, et al. Signal-regulatory protein alpha (SIRP alpha) but not SIRP beta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-)hematopoietic cells. Blood. 2001; 97: 2741-9
|
|
|
31) Wang H, Madariaga ML, Wang S, et al. Lack of CD47 on nonhematopoietic cells induces split macrophage tolerance to CD47null cells. Proc Natl Acad Sci U S A. 2007; 104: 13744-9
|
|
|